Director of Special Projects & International Growth
eMed
| Company | eMed |
| Category | Marketing |
| Location | London |
| Remote | On-site (inferred) |
| Employment | Not stated |
| Level | Director |
| Salary | Not stated by the employer |
| Posted | 17 Jul 2026 |
| Last verified | 11 Aug 2026 |
| Source | Employer ATS (greenhouse) |
Description
PURPOSE OF ROLE
eMed is redefining the future of at-home care, leveraging physical and digital technologies to cut costs, increase capacity, and improve quality of care. We're building the complete chronic condition management platform that lets patients manage chronic conditions from home, safely and at scale. Our flagship focus today is GLP-1 weight management delivered at scale, with SheMed (women-focused) and HeMed as related brands. We're an NHS partner in the UK and are actively expanding into new international markets. We're looking for a senior operator who can work directly alongside the Managing Director, moving fluidly between whatever the highest-priority problem is; right now, that's standing up a UK B2B/employer channel and driving international market readiness, but the role is deliberately built to flex as priorities shift.
This is a senior, high-autonomy role for someone who acts as a direct extension of the Managing Director, picking up whatever needs serious ownership, wherever it sits. Right now the two biggest priorities are:
Standing up eMed's UK B2B proposition: turning an existing commercial and pricing foundation into a fully operational employer/benefits channel.
Driving international expansion operations: owning market readiness, partner delivery, and country manager coordination across eMed's live and prospective international markets.
The mandate isn't fixed to these two areas. You should expect the scope to shift toward whatever's most urgent. This role suits someone who wants broad ownership and variety, not a narrowly defined lane.
2.2 WHAT YOU WILL WORK ON
UK B2B Channel Build-out
Assist with building and scaling the UK employer/B2B proposition, building on eMed's existing capitation pricing model and market positioning
Develop and execute a go-to-market strategy covering brokers, insurers, and direct employer relationships
International Growth & Operations
Drive eMed's regulatory-first market-entry approach: building for the most demanding regulatory bar in each new market before entry.
Own end-to-end operational readiness tracking across all international markets: regulatory approval, partner agreements, incorporation, and launch readiness
Manage relationships with in-market Country Managers, and lead onboarding for new markets as they come online
Coordinate cross-functional workstreams spanning regulatory approval, clinical partnerships, pharmacy and lab logistics
Identify, escalate, and resolve blockers to market entry (device approvals, care-model regulatory constraints, partner sourcing gaps)
Report readiness status and progress regularly to the leadership team, with a clear view of what's blocking each market from launch
Special Projects & Direct Support to the MD
Take direct ownership of high-priority initiatives as they arise, spanning commercial, operational, or strategic work
Act as a trusted senior deputy to the Managing Director, able to represent them in partner, regulatory, and internal discussions
Move between workstreams as priorities shift, without needing extensive ramp-up time
Present regular updates to leadership and the board across whichever priorities are live at the time
Build and lead a small team as specific workstreams scale
2.3 WHAT WE’RE LOOKING FOR:
Senior leadership experience (Director level or equivalent) in digital health, healthcare services, or another regulated, operationally complex industry
A genuine generalist operator, comfortable owning commercial, operational, and strategic work in the same week, and switching between them without losing momentum
A track record of building B2B or employer-channel commercial propositions, ideally in health, insurance, or benefits
Experience operating across multiple international regulatory environments; healthcare, pharma, or medical device experience strongly preferred
Strong comm